Previous slide
Next slide
ZRJ Pharmacueticals
Market Presence
0
+
Cities And Region
With a strong presence in 47 districts across Pakistan, our company has established itself as a key player in the national market. Beyond borders, we have successfully expanded into the Gulf region, specifically in Sharjah, Emirates, Dubai, and Qatar, showcasing our commitment to international growth. Our global footprint extends further to Singapore, highlighting our reach in key international markets. Recently, we achieved a significant milestone by obtaining a license to operate in the USA, marking a pivotal moment in our journey towards global recognition and expansion.
ZRJ
Products
Our Partners
Zululan Health provide quality nutritional supplements, medical devices and Over the Counter (OTC) products to the Middle East and North Africa (MENA) market
VIVATIS Pharma is an independent full-service providers for manufacturers, of pharmaceuticals (generics and product synthesis), cosmetics nutraceuticals, food (including luxury and functional food), sports nutrition and detergent sectors.
GENNEC as our Manufacturig Facility is unlocking Community knowledge in a new way. Experts add insights dirctly into each article, started with the help of AI. Explore More
Fonterra is a global dairy nutrition co-operative owned by ~10,000 New Zealand farmers and their families.
Fonterra produces best quality Raw materials
Fonterra produces best quality Raw materials
Accreditation & Certifications
Blogs
Health & Wellness
MORNIG SIKNESS, A Rising Concern.
September 1, 2024
Morning sickness is one of the most common symptoms experienced by pregnant women, typically during the first trimester. Despite its
INTRAUTRINE GROWTH RESTRICTION (IUGR)
August 16, 2024
Intrauterine growth restriction (IUGR) is a condition where the growth of the foetus is restricted and the foetus is smaller
Top 10 Causes of Urinary Tract Infections (UTI) – A Comprehensive Guide
August 16, 2024
July 31, 2024UTI3 Min Read Top 10 Causes of Urinary Tract Infections (UTI) – A Comprehensive Guide July 31, 2024UTI3